Flinders Medical Centre

Phase	Trial	Trial Status	Site Status	Drug [desc]	NCT#
3	Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib	Terminated	Closed	IPI-504	NCT00688766
2	REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response	Ongoing, but not recruiting	Closed	Imatinib, Nilotinib
2	A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)	Unknown	Active	Imatinib + Regorafenib	NCT02365441
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722